Stem Cell Trial Update: Feb. 19th, 2013

A meeting has been set for March 6th in Washington, D.C. between officials involved in Food and Drug Administration (FDA) oversight of clinical trials and Tisch MS Research Center senior staff. This is a long-awaited meeting and through it we hope to obtain guidance on how to proceed with our proposal for a clinical trial of stem cells in the treatment of multiple sclerosis. A further update will be provided in this space after March 6th.